Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure

Paul M. McKie, John A. Schirger, Sherry L. Benike, Lynn K. Harstad, Joshua P. Slusser, David O. Hodge, Margaret M. Redfield, John C. Burnett, Horng H. Chen

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Aims We have previously reported that asymptomatic systolic heart failure (HF) is characterized by an impaired renal response to volume expansion due to lack of activation of urinary cGMP which is corrected by subcutaneous (SQ) BNP. In the current study, we sought to define the cardiorenal response to intravascular volume expansion after 12 weeks of SQ BNP therapy. Methods and results We utilized a double-blinded, placebo-controlled study to compare 12 weeks of twice-daily SQ BNP 10 μg/kg (n = 22) or placebo (n = 12) in asymptomatic systolic HF. Subjects underwent two study visits: baseline and after 12 weeks of therapy. At each study visit, echocardiography, renal, and neurohumoral assessments were performed before and after intravascular volume expansion. The primary endpoint was change in urinary sodium excretion in response to volume expansion at 12 weeks, and we observed a greater increase in urinary sodium excretion [166 (77, 290) vs. 15 (-39, 72) mEq/min; P = 0.02] with SQ BNP treatment vs. placebo. Secondary endpoints included change in urine flow and glomerular filtration rate (GFR) in response to volume expansion at 12 weeks. We observed a significant increase in urine flow (P < 0.01) and trend for differential response in GFR (P = 0.08) with SQ BNP treatment vs. placebo. Conclusion Among patients with asymptomatic systolic HF, twice-daily SQ BNP therapy improved the cardiorenal response to volume expansion at 12-week follow-up. Further studies are warranted to determine if these beneficial physiological observations with chronic natriuretic peptide administration translate into a delay in the progression to symptomatic HF.

Original languageEnglish (US)
Pages (from-to)433-441
Number of pages9
JournalEuropean Journal of Heart Failure
Issue number4
StatePublished - Apr 1 2016


  • Asymptomatic
  • Heart failure
  • Natriuretic peptides
  • Renal

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure'. Together they form a unique fingerprint.

Cite this